SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUM.L Regulatory News (NUM)

  • There is currently no data for NUM

Trading update

6 Feb 2018 07:00

RNS Number : 9779D
Numis Corporation PLC
06 February 2018
 

Numis Corporation Plc ("Numis")

 

Embargoed for release 7.00 am, 6 February 2018

 

 

Numis today provides the following trading update in relation to the period from 1 October 2017. This statement is issued in advance of the Company's Annual General Meeting which is being held at 12 noon today. 

Trading Update

Numis has experienced a very strong start to the year, with revenues significantly ahead of the comparable period last year and with continued momentum across the business. We have benefited from an increase in overall transaction volumes and materially higher average fees compared to a relatively slow start to the prior year.

Encouragingly, our performance has been driven by robust trading across both the Equities and Corporate Broking & Advisory sides of the business. Our retained corporate client base continues to deliver high quality transaction activity, with our revenue growth being driven predominantly by a pick-up in clients accessing the equity capital markets and greater M&A derived revenue. Of note, we acted on the $546m equity raise for Catco Reinsurance, the IPO of Sabre Insurance Group and as Financial Adviser in relation to the £281m recommended cash offer for SQS Software Quality Systems AG.

Similarly, the Equities division has continued the good performance from the second half of the previous financial year and delivered revenue materially ahead of the same period last year. MiFID II came into effect on 3 January 2018 and whilst it is too early to fully assess the likely financial impact of the regulation, we are encouraged by the level of engagement, and response from our institutional clients which we believe is indicative of the overall strength of our research, sales and execution capability.

Our current pipeline is promising, including IPOs, capital raising and M&A opportunities. Converting this will, as ever, depend on favourable market conditions continuing. However we believe the business is well positioned following a strong start to the financial year. 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

 

6 February 2018

 

END

 

Contacts

 

Alex Ham and Ross Mitchinson Co-CEOs 020 7260 1245

Andrew Holloway - Chief Financial Officer 020 7260 1266

 

Brunswick:

Nick Cosgrove 020 7404 5959

Simone Selzer 020 7404 5959

 

Grant Thornton UK LLP (Nominated Adviser):

Philip Secrett 020 7728 2578

Jen Clarke 020 7865 2411

Harrison J Clarke 020 7184 4384

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVAWRWSAURAR
Date   Source Headline
23rd Jan 20171:00 pmRNSDirectors' Dealing
19th Jan 20172:00 pmRNSDirectors' Dealing
18th Jan 201711:00 amRNSDirector's Dealing
12th Jan 201711:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Jan 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Jan 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Jan 20179:51 amRNSAnnual Report and Annual General Meeting Notice
3rd Jan 201710:38 amRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Dec 20163:00 pmRNSTransaction in Own Shares and Total Voting Rights
9th Dec 201611:05 amRNSHolding(s) in Company
7th Dec 20167:00 amRNSPreliminary Results for the year ended 30 Sep 2016
1st Dec 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Nov 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Nov 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Nov 20162:00 pmRNSTransaction in Own Shares and Total Voting Rights
4th Nov 20162:00 pmRNSDirector's Dealing
27th Oct 20161:00 pmRNSTransaction in Own Shares and Total Voting Rights
19th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Oct 201611:00 amRNSPurchase of shares in Close Period
3rd Oct 20167:00 amRNSTrading Update
14th Sep 20167:00 amRNSHolding(s) in Company
6th Sep 20169:45 amRNSDirector/PDMR Shareholding
5th Sep 20164:42 pmRNSGrant of Share Awards
22nd Aug 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Aug 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Aug 20163:11 pmRNSTransaction in Own Shares and Total Voting Rights
1st Aug 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Jul 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Jul 201611:30 amRNSTransaction in Own Shares and Total Voting Rights
7th Jul 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Jul 20167:00 amRNSBoard Appointments
29th Jun 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Jun 201612:07 pmRNSSecond Price Monitoring Extn
27th Jun 201612:02 pmRNSPrice Monitoring Extension
22nd Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Jun 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Jun 201611:47 amRNSDirector's Dealing
24th May 20163:16 pmRNSPosting of Interim Report
23rd May 20163:00 pmRNSHolding(s) in Company
19th May 20162:12 pmRNSTransaction in Own Shares and Total Voting Rights
19th May 201610:00 amRNSTransfer of Shares from Treasury to EBT and TVR
13th May 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
9th May 20169:39 amRNSTransfer of Shares from Treasury to EBT and TVR
6th May 20167:01 amRNSBoard Changes
6th May 20167:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.